-
The p53 tumour suppressor gene.
Nature. 1991 Jun 6;351(6326):453-6
PMID: 2046748
-
Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.
J Pathol. 1992 Sep;168(1):85-6
PMID: 1453271
-
p53 mutations in human cancers.
Science. 1991 Jul 5;253(5015):49-53
PMID: 1905840
-
Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases.
Am J Clin Pathol. 1991 Jul;96(1):15-24
PMID: 1712540
-
Silver enhancement of nickel-diaminobenzidine as applied to single and double immunoperoxidase staining.
Biotech Histochem. 1991;66(3):159-67
PMID: 1716167
-
p53 mutations in ovarian cancer: a late event?
Oncogene. 1991 Sep;6(9):1685-90
PMID: 1923532
-
Polymorphism at codon 213 within the p53 gene.
Oncogene. 1991 Sep;6(9):1691-2
PMID: 1923533
-
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours.
Oncogene. 1991 Sep;6(9):1693-7
PMID: 1923534
-
Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.
Cancer Res. 1992 Mar 1;52(5):1369-71
PMID: 1737400
-
Clonal expansion of p53 mutant cells is associated with brain tumour progression.
Nature. 1992 Feb 27;355(6363):846-7
PMID: 1311419
-
A new TaqI polymorphism in the p53 gene.
Nucleic Acids Res. 1992 Feb 25;20(4):928
PMID: 1347421
-
The aetiology of thyroid tumours.
Clin Endocrinol Metab. 1979 Mar;8(1):193-207
PMID: 428139
-
Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
Cancer. 1983 Nov 15;52(10):1849-55
PMID: 6313176
-
Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma".
Am J Surg Pathol. 1984 Sep;8(9):655-68
PMID: 6476195
-
Prognostic implications of the tall cell variant of papillary thyroid carcinoma.
Am J Surg Pathol. 1988 Jan;12(1):22-7
PMID: 3337337
-
Improved double-stranded DNA sequencing using the linear polymerase chain reaction.
Nucleic Acids Res. 1989 Nov 11;17(21):8889
PMID: 2587244
-
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.
Oncogene. 1989 Dec;4(12):1457-62
PMID: 2594368
-
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Cell. 1990 Feb 23;60(4):557-63
PMID: 2406025
-
Presence of mutations in all three ras genes in human thyroid tumors.
Oncogene. 1990 Apr;5(4):565-70
PMID: 2183158
-
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
EMBO J. 1990 May;9(5):1595-602
PMID: 1691710
-
Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases.
Cancer. 1990 Jul 15;66(2):321-30
PMID: 1695118
-
Structural aspects of the p53 protein in relation to gene evolution.
Oncogene. 1990 Jul;5(7):945-52
PMID: 2142762
-
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
Oncogene. 1990 Oct;5(10):1603-10
PMID: 1979160
-
Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation.
Oncogene. 1991 Mar;6(3):471-3
PMID: 2011403
-
The trk proto-oncogene encodes a receptor for nerve growth factor.
Cell. 1991 Apr 5;65(1):189-97
PMID: 1849459
-
High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
Cancer Res. 1991 May 15;51(10):2690-3
PMID: 2021946
-
Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.
J Histochem Cytochem. 1991 Jun;39(6):741-8
PMID: 1709656
-
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Oncogene. 1992 Feb;7(2):237-42
PMID: 1532241
-
Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes.
Histopathology. 1992 Mar;20(3):243-50
PMID: 1563711
-
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
J Clin Invest. 1992 May;89(5):1517-22
PMID: 1569189
-
P53 in tumour pathology: can we trust immunocytochemistry?
J Pathol. 1992 Apr;166(4):329-30
PMID: 1517889
-
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.
Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5413-7
PMID: 2052620